Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1992 1
1995 1
1996 1
1997 1
1998 2
2000 1
2003 1
2004 1
2005 1
2007 2
2008 1
2010 4
2011 2
2012 3
2015 1
2018 1
2019 2
2020 3
2021 1
2022 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Results by year

Filters applied: . Clear all
Page 1
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial.
Perrone F, Piccirillo MC, Ascierto PA, Salvarani C, Parrella R, Marata AM, Popoli P, Ferraris L, Marrocco-Trischitta MM, Ripamonti D, Binda F, Bonfanti P, Squillace N, Castelli F, Muiesan ML, Lichtner M, Calzetti C, Salerno ND, Atripaldi L, Cascella M, Costantini M, Dolci G, Facciolongo NC, Fraganza F, Massari M, Montesarchio V, Mussini C, Negri EA, Botti G, Cardone C, Gargiulo P, Gravina A, Schettino C, Arenare L, Chiodini P, Gallo C; TOCIVID-19 investigators, Italy. Perrone F, et al. J Transl Med. 2021 Oct 21;19(1):442. doi: 10.1186/s12967-021-03094-9. J Transl Med. 2021. PMID: 34674735 Free PMC article. No abstract available.
Covid19: Could other alternatives have been possible?
Bertolini A, Maiolani M, Menatti E, Barbonetti C, Stiglich F, Valenti D, Fregoni V. Bertolini A, et al. Among authors: fregoni v. J Glob Antimicrob Resist. 2020 Sep;22:45-46. doi: 10.1016/j.jgar.2020.05.010. Epub 2020 Jun 3. J Glob Antimicrob Resist. 2020. PMID: 32504843 Free PMC article. No abstract available.
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial.
Perrone F, Piccirillo MC, Ascierto PA, Salvarani C, Parrella R, Marata AM, Popoli P, Ferraris L, Marrocco-Trischitta MM, Ripamonti D, Binda F, Bonfanti P, Squillace N, Castelli F, Muiesan ML, Lichtner M, Calzetti C, Salerno ND, Atripaldi L, Cascella M, Costantini M, Dolci G, Facciolongo NC, Fraganza F, Massari M, Montesarchio V, Mussini C, Negri EA, Botti G, Cardone C, Gargiulo P, Gravina A, Schettino C, Arenare L, Chiodini P, Gallo C; TOCIVID-19 investigators, Italy. Perrone F, et al. J Transl Med. 2020 Oct 21;18(1):405. doi: 10.1186/s12967-020-02573-9. J Transl Med. 2020. PMID: 33087150 Free PMC article. Clinical Trial.
Venous thromboembolism secondary to hospitalization for COVID-19: patient management and long-term outcomes.
Ageno W, Antonucci E, Poli D, Bucherini E, Chistolini A, Fregoni V, Lerede T, Pancani R, Pedrini S, Pieralli F, Pignatelli P, Pizzini AM, Podda GM, Potere N, Sarti L, Testa S, Visonà A, Palareti G; START 2 Registry VTE study group. Ageno W, et al. Among authors: fregoni v. Res Pract Thromb Haemost. 2023 May;7(4):100167. doi: 10.1016/j.rpth.2023.100167. Epub 2023 Apr 26. Res Pract Thromb Haemost. 2023. PMID: 37229314 Free PMC article.
Hypopituitarism and antiphospholipid syndrome.
Pandolfi C, Gianini A, Fregoni V, Nalli G, Faggi L. Pandolfi C, et al. Among authors: fregoni v. Minerva Endocrinol. 1997 Dec;22(4):103-5. Minerva Endocrinol. 1997. PMID: 9586417
Paclitaxel in anthracycline-treated breast cancer patients.
Pugliese P, Brugnatelli S, Giordano M, Danova M, De Monte A, Richetti A, Fava S, Rinaldi E, Fregoni V, Epifani C, Riccardi A. Pugliese P, et al. Among authors: fregoni v. Oncol Rep. 1998 Jul-Aug;5(4):915-8. doi: 10.3892/or.5.4.915. Oncol Rep. 1998. PMID: 9625845 Clinical Trial.
Thromboembolic Complications in COVID-19 Patients Hospitalized in Italian Ordinary Wards: Data from the Multicenter Observational START-COVID Register.
Poli D, Antonucci E, Ageno W, Prandoni P, Barillari G, Bitti G, Imbalzano E, Bucherini E, Chistolini A, Fregoni V, Galliazzo S, Gandolfo A, Grifoni E, Mastroianni F, Panarello S, Pesavento R, Pedrini S, Sala G, Pignatelli P, Preti P, Simonetti F, Sivera P, Visonà A, Villalta S, Marcucci R, Palareti G. Poli D, et al. Among authors: fregoni v. TH Open. 2022 Sep 12;6(3):e251-e256. doi: 10.1055/a-1878-6806. eCollection 2022 Jul. TH Open. 2022. PMID: 36299804 Free PMC article.
Targeting the EWS-FLI1 transcription factor in Ewing sarcoma.
Tancredi R, Zambelli A, DaPrada GA, Fregoni V, Pavesi L, Riccardi A, Burdach S, Grohar PJ, D'Incalci M. Tancredi R, et al. Among authors: fregoni v. Cancer Chemother Pharmacol. 2015 Jun;75(6):1317-20. doi: 10.1007/s00280-015-2726-7. Epub 2015 Mar 26. Cancer Chemother Pharmacol. 2015. PMID: 25809543
Multicenter, single arm, phase II trial on the efficacy of ortataxel in recurrent glioblastoma.
Silvani A, De Simone I, Fregoni V, Biagioli E, Marchioni E, Caroli M, Salmaggi A, Pace A, Torri V, Gaviani P, Quaquarini E, Simonetti G, Rulli E, D'Incalci M; Italian Association of Neuro-Oncology. Silvani A, et al. Among authors: fregoni v. J Neurooncol. 2019 May;142(3):455-462. doi: 10.1007/s11060-019-03116-z. Epub 2019 Feb 6. J Neurooncol. 2019. PMID: 30726533 Clinical Trial.
31 results